Back to Search
Start Over
Monitoring and treatment of anti-D in pregnancy
- Source :
- Vox Sanguinis, 99, 2, pp. 177-92, Vox Sanguinis, 99, 177-92, Vox sanguinis, 99(2), 177-192. Wiley-Blackwell, Bettelheim, D, Panzer, S, Reesink, H W, Csapo, B, Pessoa, C, Guerra, F, Wendel, S, Calda, P, Sprogøe, U, Dziegiel, M, Aitokallio-Tallberg, A, Koskinen, S, Kuosmanen, M, Legler, T J, Stein, W, Villa, S, Villa, M A, Trespidi, L, Acaia, B, Vandenbussche, F P H A, Brand, A, Haas, I M D, Kanhai, H H H, Gounder, D, Flanagan, P, Donegan, R, Parry, E, Sefonte, C, Skulstad, S M, Hervig, T, Flesland, Ø, Zupańska, B, Uhrynowska, M, Lapaire, O, Zhong, X Y & Holzgreve, W 2010, ' Monitoring and treatment of anti-D in pregnancy ', Vox Sanguinis, vol. 99, no. 2, pp. 177-92 . https://doi.org/10.1111/j.1423-0410.2010.01322.x
- Publication Year :
- 2010
-
Abstract
- Prophylactic anti-D is a very safe and effective therapy for the suppression of anti-D immunization and thus prevention of haemolytic disease of the foetus and newborn. However, migration from countries with low health standards and substantial cuts in public health expenses have increased the incidence of anti-D immunization in many "developed" countries. Therefore, this forum focuses on prenatal monitoring standards and treatment strategies in pregnancies with anti-D alloimmunization. The following questions were addressed, and a response was obtained from 12 centres, mainly from Europe.
- Subjects :
- medicine.medical_specialty
Pediatrics
Rho(D) Immune Globulin
030204 cardiovascular system & hematology
Rh Isoimmunization
Blood group antigens
03 medical and health sciences
0302 clinical medicine
Isoantibodies
Pregnancy
Medicine
Humans
Intensive care medicine
Fetal Hemoglobin
030219 obstetrics & reproductive medicine
Rh-Hr Blood-Group System
Cardiovascular diseases [NCEBP 14]
business.industry
Incidence (epidemiology)
Public health
Pregnancy Complications, Hematologic
Hematology
General Medicine
medicine.disease
Fetal Blood
3. Good health
Immunization
Blood Group Antigens
Treatment strategy
Female
business
Haemolytic disease
Subjects
Details
- ISSN :
- 14230410 and 00429007
- Volume :
- 99
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Vox sanguinis
- Accession number :
- edsair.doi.dedup.....1e3588c111a0ad53e6d472b9aa138610
- Full Text :
- https://doi.org/10.1111/j.1423-0410.2010.01322.x